Tarsus Pharmaceuticals, Inc. TARS Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Tarsus Pharmaceuticals, Inc. (TARS) reported accrued manufacturing costs of $8.53M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s accrued manufacturing costs changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s accrued manufacturing costs decreased by 14.1% year-over-year, from $9.93M to $8.53M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s accrued manufacturing costs has grown at a 76.4% compound annual growth rate (CAGR), from $1.04M to $17.78M.